Tech Company M&A Transactions
Zymergen Acquisition
On 7/25/2022, Zymergen was bought by Ginkgo Bioworks. The transaction price was $300 million.
Transaction Overview
Company Name
Acquired By
Announced On
7/25/2022
Transaction Type
M&A
Amount
$300,000,000
M&A Terms
Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
5980 Horton St. 105
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
At Zymergen, we make improvements to microbes used in industrial fermentation. With advanced automation and computation, we build enhanced strains for real world applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Hoffman
Chief Marketing Officer
Jack Gold
Chief Scientific Officer
Zach Serber
Chief Technical Officer
Aaron Kimball
VP - Finance
Enakshi Singh
VP - Human Resources
Judy Gilbert
VP - Human Resources
Mina Kim
VP - Operations
Jed Dean
VP - Product Management
Richard Pieters
Browse more venture capital transactions:
Prev: 7/25/2022: Alchemon venture capital transaction
Next: 7/25/2022: Bandit venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs